Publications

Malaria transmission potential of Anopheles gambiae s.l. in indoor residual spraying areas with clothianidin 50 WG in northern Benin.

Odjo, EM; Tognidro, M; GOVOETCHAN, R; Missihoun, AA; Padonou, GG; Ahouandjinou, JM; Akinro, B; Koukpo, ZC; Tokponnon, FT; Djenontin, A; Agbangla, C; Akogbeto, MC;

2024

Tropical Medicine and Health, (2024).52 1 10.1186/s41182-024-00582-8.

Is qualitative social research in global health fulfilling its potential?: a systematic evidence mapping of research on point-of-care testing in low- and middle-income contexts.

Perkins, J; Nelson, S; Birley, E; Mcswiggan, E; Dozier, M; McCarthy, A; Atkins, N; Agyei-Manu, E; Rostron, J; Kameda, K; Kelly, A; CHANDLER, C; Street, A;

2024

BMC health services research, (2024).24 1 10.1186/s12913-024-10645-5.

Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5–10-Year-Old Burkinabe Children Naturally Exposed to Malaria.

Nebie, I; Palacpac, NM Q; Bougouma, EC; Diarra, A; Ouédraogo, A; D'Alessio, F; Houard, S; Tiono, AB; COUSENS, S; Horii, T; Sirima, SB;

2024

Vaccines, (2024).12 2 10.3390/vaccines12020166.

Monitoring of Fabric Integrity and Attrition Rate of Dual-Active Ingredient Long-Lasting Insecticidal Nets in Tanzania: A Prospective Cohort Study Nested in a Cluster Randomized Controlled Trial.

MARTIN, J; Lukole, E; Messenger, LA; Aziz, T; Mallya, E; Bernard, E; MATOWO, NS; Mosha, JF; ROWLAND, M; Mosha, FW; Manjurano, A; Protopopoff, N;

2024

Insects, (2024).15 2 10.3390/insects15020108.

Statistical report, Malaria Vaccine Pilot Evaluation (MVPE), analysis of data to month 46.

FOGELSON, A; Milligan, P;

2024

(2024).

Malaria seroepidemiology in very low transmission settings in the Peruvian Amazon.

Fernandez-Camacho, B; Peña-Calero, B; Guillermo-Roman, M; Ruiz-Cabrejos, J; Barboza, JL; Bartolini-Arana, L; Barja-Ingaruca, A; Rodriguez-Ferrucci, H; Soto-Calle, VE; Nelli, L; BYRNE, I; Hill, M; Dumont, E; GRIGNARD, L; Tetteh, K; Wu, L; Llanos-Cuentas, A; DRAKELEY, C; Stresman, G; Carrasco-Escobar, G;

2024

Scientific reports, (2024).14, 10.1038/s41598-024-52239-5.

Malaria vaccines for children: and now there are two.

Moorthy, V; Hamel, MJ; SMITH, PG;

2024

Lancet, (2024).403 10426 10.1016/S0140-6736(23)02743-5.

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.

Datoo, MS; Dicko, A; Tinto, H; Ouédraogo, J-B; Hamaluba, M; Olotu, A; BEAUMONT, E; Ramos Lopez, F; Natama, HM; Weston, S; Chemba, M; Compaore, YD; Issiaka, D; Salou, D; Some, AM; Omenda, S; Lawrie, A; Bejon, P; Rao, H; CHANDRAMOHAN, D; Roberts, R; Bharati, S; Stockdale, L; Gairola, S; GREENWOOD, BM; ... R21/Matrix-M Phase 3 Trial Group,

2024

Lancet (London, England), (2024).403 10426 10.1016/S0140-6736(23)02511-4.

Is Brazil reaching malaria elimination? A time series analysis of malaria cases from 2011 to 2023.

GARCIA, KK S; SOREMEKUN, S; Abrahão, AA; Marchesini, PB; DRAKELEY, C; Ramalho, WM; Siqueira, AM;

2024

PLOS Global Public Health, (2024).4 1 10.1371/journal.pgph.0002845.

Is Brazil reaching malaria elimination? A time series analysis of malaria cases from 2011 to 2023.

Garcia, KK S; Soremekun, S; Abrahão, AA; Marchesini, PB; DRAKELEY, C; Ramalho, WM; Siqueira, AM;

2024

, PLOS Global Public Health (2024).